Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta-Analysis and Trial Sequential Analysis

Figure 4

Trial sequential analysis for the meta-analysis of XRCC3 rs861539 and ovarian cancer risk under (a) GA vs. GG and (b) GG vs. GA+AA.

(a)

(b)